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Background: The distribution of blood flow in fetuses with congenital heart disease (CHD) is likely to influence
fetal growth, organ development, and postnatal outcome, but has previously been difficult to study. We present
the first measurements of the distribution of the fetal circulation in left-sided CHD made using phase contrast
cardiac magnetic resonance (CMR).
Methods: Twenty-two fetuses with suspected left-sided CHD and twelve normal controls underwent fetal CMR and
echocardiography at a mean of 35 weeks gestation (range 30–39 weeks).
Results: Fetuses with left-sided CHD had a mean combined ventricular output 19% lower than normal controls
(p < 0.01). In fetuses with left-sided CHD with pulmonary venous obstruction, pulmonary blood flow was significantly
lower than in those with left-sided CHD without pulmonary venous obstruction (p < 0.01). All three fetuses with
pulmonary venous obstruction had pulmonary lymphangectasia by fetal CMR and postnatal histology. Fetuses with
small but apex forming left ventricles with left ventricular outflow tract or aortic arch obstruction had reduced
ascending aortic and foramen ovale flow compared with normals (p < 0.01). Fetuses with left-sided CHD had more
variable superior vena caval flows than normal controls (p < 0.05). Six fetuses with CHD had brain weights at or
below the 5th centile for gestational age, while none of the fetuses in the normal control group had brain weights
below the 25th centile.
Conclusions: Measurement of the distribution of the fetal circulation in late gestation left-sided CHD is feasible with
CMR. We demonstrated links between fetal blood flow distribution and postnatal course, and examined the
relationship between fetal hemodynamics and lung and brain development. CMR enhances our understanding of
pathophysiology of the fetal circulation and, with more experience, may help with the planning of perinatal
management and fetal counselling.Background
Left-sided congenital heart disease (CHD) includes a
spectrum of abnormalities of the left ventricular inflow,
ventricle, outflow tract, and aortic arch [1]. Left-sided
CHD is accurately diagnosed with fetal echocardiog-
raphy, which aids parental counselling, preparation for* Correspondence: mike.seed@sickkids.ca
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reproduction in any medium, provided the ordelivery, and postnatal management [2]. Selected
mothers are now increasingly being offered fetal inter-
ventions in an attempt to modify the course of severe
aortic stenosis and hypoplastic left heart syndrome
(HLHS) with an intact or highly restrictive atrial septum
(I/HRAS) [3].
Although ultrasound provides a wealth of physiologic
information in these fetuses, the assessment of blood flow,
one of the key parameters of hemodynamics, is technically
difficult by ultrasound. Inaccuracies arise from problems
obtaining an adequate angle of insonation, vessel area
measurement, and assessment of variations in blood flow
velocity across the vessel lumen [4,5]. In recent yearsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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CMR) has gained importance as a clinical tool for blood
flow quantification in postnatal patients with cardiovascu-
lar disease [6]. Cardiovascular magnetic resonance (CMR)
is a widely available and safe technique for imaging the
fetus and we have recently validated a PC CMR technique
with metric optimised gating for use in late gestation fetal
subjects [7,8].
Measurement of the distribution of fetal blood flow is
potentially of interest to those caring for fetuses with
CHD as it may provide new information about the im-
pact of fetal hemodynamics on growth and development.
For example, reduced flow through the left heart has
been suggested as a cause for the progression of left-
sided valve stenosis to HLHS [9], while abnormal cere-
bral perfusion has been implicated in the delayed brain
development seen in fetuses with CHD [10]. In the set-
ting of pulmonary venous obstruction (PVO), abnormal
fetal cardiovascular physiology results in fetal pulmonary
vascular disease causing severe hypoxia in the newborn,
which may require emergency neonatal intervention
[11]. Fetal MR also allows measurement of other physio-
logic variables that might be affected by abnormal
hemodynamics such as cell metabolism, fetal brain size,
and lung architecture [12-14]. The aim of this study was
to evaluate the impact of various forms of left-sided
CHD on blood flow using PC CMR. We also aimed to
investigate the relationship between fetal hemodynamics
and postnatal outcome and lung and brain development.Methods
This manuscript describes a single centre prospective
cross-sectional case control study conducted between
2010 and 2012.Study population
Twenty-two pregnant women were recruited to undergo
a fetal CMR after possible left-sided CHD was detected
by fetal echocardiography at our institution. During the
same study period, twelve normal controls were studied
with the same technique at a similar range of gestational
age. The results of this control group have been reported
in our previous paper [8]. The fetuses were all studied
during the third trimester with a median gestational age
of 35 weeks and range of 30–39 weeks. Three subjects
underwent fetal intervention to decompress pulmonary
venous obstruction with CMR performed before and
after the interventional procedure. The Hospital for Sick
Children research ethics board approved the research
protocol, and the expectant mothers gave written con-
sent for CMR.
The fetuses were divided into four groups based on
anatomical and physiologic type:Group 1 Normal (n = 12): late gestation healthy
controls.
Group 2 Aortic stenosis (AS) and/or aortic coarctation
(CoA) (n = 7): fetuses with a small but apex
forming LVs and aortic stenosis and/or a
hypoplastic aortic arch or aortic coarctation
with or without mitral stenosis (MS) but
without PVO.
Group 3 Hypoplastic left heart syndrome (HLHS) with
unrestrictive atrial septum (UAS) (n = 12):
fetuses with HLHS with aortic atresia (AA) or
severe AS with an UAS.
Group 4 HLHS with intact or highly restrictive atrial
septum (I/HRAS) (n = 3).
There were no genetic syndromes identified in our co-
hort. One subject with coarctation had an Arnold Chiari
malformation.
CMR protocol
We performed the studies using a 1.5 T CMR system
(Siemens Avanto, Erlangen, Germany). The CMR studies
were performed on the same day as the last of three pre-
natal echocardiograms. Blood flow in the major fetal
vessels was measured using PC CMR with metric opti-
mized gating according to our previously published tech-
nique [8]. Measurements were made in the main
pulmonary artery (MPA), ductus arteriosus (DA), super-
ior vena cava (SVC), descending aorta (DAo) and umbil-
ical vein (UV) [8]. Where possible, the ascending aorta
(AAo) and right and left pulmonary arteries (RPA &
LPA) were interrogated. A stack of T2 weighted single
shot fast spin echo with half Fourier acquisition
(HASTE) slices were prescribed axial to the fetal thorax
and head to image the lungs and brain (slice thickness 5
mm, matrix size 320 × 256, field of view 350 mm, 50%
phase oversampling, parallel imaging factor of 2, 1 aver-
age, echo time 145 ms, repetition time 1250 ms, scan
time 1.3 s per slice). The entire examination was gener-
ally completed in 45 minutes, and the maximum time
allowed for any study was one hour.
CMR data analysis
Two radiologists (MS, BAN) post-processed every flow
measurement using commercial software (Q-flow,
Medis, Netherlands). Flows were indexed to the fetal
weight according to our previously published technique
[8]. The fetal weight was estimated from the fetal vol-
ume using a conversion factor based on fetal density
developed by Baker et al.: 0.12 + 1.031 × fetal volume
(ml) =MR weight (g) [15]. We used the same volumetry
technique to estimate fetal brain volumes, and converted
these to brain weights assuming a brain specific gravity
of 1.04, based on a previously published conversion [16].
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mated as the sum of the MPA and AAo flows, account-
ing for an estimate of coronary blood flow of 3% of
CVO, based on previous lamb data [17]. In fetuses with
aortic atresia, the coronary blood flow is derived from
the MPA flow via retrograde flow in the aortic arch.
Flow in each vessel was expressed as net flow in ml/
min/kg body weight. We were not able to measure the
AAo flow in subjects with AA or severe AS due to the
small size of the aorta. In seven fetuses with CHD and
four normal fetuses we were not able to measure pul-
monary blood flow (PBF) directly because of small vessel
size and fetal motion. In those subjects, PBF was calcu-
lated from the difference between MPA and DA flow.
Foramen ovale (FO) flow was estimated as the difference
between the left ventricular output and PBF.
The HASTE imaging was reviewed to assess the lungs
for the possibility of pulmonary lymphangectasia (PL).
Visualization of high signal branching linear structures
extending to the surface of the lung was required to
make the radiologic diagnosis [14,18]. Lung histologic
examination was performed after lung biopsy or during
autopsy in all subjects with suspected PL.
Echocardiography
According to the usual clinical protocol at our institution,
an extensive prenatal and postnatal echocardiogram was
performed in all subjects by one of five attending cardiolo-
gists. This included two-dimensional anatomical and
hemodynamic assessment with colour flow and Doppler
imaging. The diagnosis was generally made at around
20 weeks gestation, with follow up echocardiography at
roughly 28 and 35 weeks gestation. The postnatal echocar-
diogram was performed within 24 hours of birth in all
cases. Fetal cardiac anatomical assessment included a full
sequential segmental analysis. The sizes of left-sided car-
diac structures were measured and the presence of ob-
struction of pulmonary venous drainage, left ventricular
inflow and outflow, and aortic arch obstruction and valve
morphology were documented. The direction of blood
flow in the aortic arch, the presence of an aortic coarcta-
tion, and any associated restriction of antegrade or retro-
grade aortic isthmus flow were investigated. Atrial septal
restriction was assessed with 2D imaging and with colour
and Doppler, including the ratio of antegrade to retro-
grade pulmonary vein velocity time integral (PV VTI),
with a VTI ratio of less than five regarded as being consist-
ent with PVO [19]. An assessment of cerebral vascular
tone was performed with middle cerebral artery Doppler
[20]. The possibility of placental insufficiency was investi-
gated with umbilical artery (UA) Doppler and fetal biom-
etry [21]. Postnatal echocardiography was performed
according the guidelines published by the American Soci-
ety of Echocardiography [22].Clinical outcome
The clinical outcome of each fetus with left-sided CHD
was recorded, including birth weight and gestational age
at birth, postnatal oxygen saturation range, surgical ap-
proach used, and length of time on the intensive care
unit. Death or serious morbidity was noted with a vari-
able follow up period from 1 to 24 months of age.
Statistical analysis
Blood flows are expressed in ml/min/kg body weight. A
two-tailed, unpaired t-test with unequal variance was
used to compare flows between groups and Levene’s test
was used to assess equality of variances. A model of the
distribution of blood flows, as a percentage of CVO,
was extrapolated from measured flows based on a
constrained nonlinear optimization satisfying conserva-
tion of flow throughout the fetal circulatory system.
Pearson’s correlation was used to investigate relation-
ships with non-PC CMR measures. Statistical analyses
were performed in MATLAB (Mathworks, USA).
Results
Table 1 shows the demographic details of all subjects
with suspected left-sided CHD. The mean and range of
blood flows for each group are shown in Table 2. The
demographic details and individual flows of the 12 sub-
jects in the control group are given in our previous
paper [8]. Figure 1 shows modelled flow distributions, as
a percentage of CVO, for the entire fetal circulatory sys-
tem, for each group.
Ventricular output and type of surgical repair
Figure 2a shows the CVO for normal fetuses (Group 1),
fetuses with HLHS (Groups 3 and 4), and fetuses with
AS/CoA (Group 2). The mean CVO was 19% lower in
fetuses with CHD than normals (p = 0.009), with no sig-
nificant difference between fetuses with HLHS and AS/
CoA. One fetus with HLHS with I/HRAS had a CVO of
114 ml/min/kg, dramatically lower than any other sub-
ject. This measurement was obtained 24 hours after
atrial septal stenting, a procedure complicated by a myo-
cardial infarction, which resulted in fetal demise the
same day. One fetus with HLHS underwent late termin-
ation of pregnancy. All other fetuses with HLHS under-
went single ventricle palliation, either with a Norwood
procedure or Hybrid (stenting of the arterial duct and
bilateral branch pulmonary artery banding) in the first
days of life.
In our normal control group, the mean contributions
of the right and left ventricles to the CVO were 327 ml/
min/kg (60% of CVO) and 214 ml/min/kg (40% of
CVO), respectively. In subjects with AS/CoA (Group 2),
the mean relative contributions of the right and left
ventricles were 351 ml/min/kg (78% of CVO) and










Group 1 Normal (n = 12)
Normal No surgery [2.0,4.0] [30,39] [37,41] 0 survived
Group 2 AS/CoA (n = 7)
THAA Hybrid, biventricular repair 2.9 37 37 68 survived
MS, AS Ross and MV replacement 3.1 34 37 20 survived
CoA Coarctation repair 3.2 34 38 2 survived
CoA Coarctation repair 3.2 35 38 8 survived
MS, AS Hybrid 3.6 38 38 6 survived
MS, THAA, VSD Coarctation/VSD repair, resection
supramitral ring
3.1 36 40 14 survived
CoA, Arnold-Chiari
malformation
Coarctation repair 3.4 35 40 17 survived
Group 3 HLHS UAS (n = 12)
HLHS UAS, MS, AA Norwood 3.2 33 39 29 survived
HLHS UAS, MS, AA no surgery NA 34 NA NA termination of pregnancy
(35 weeks GA)
HLHS UAS, MS, AA Hybrid 3.6 34 40 18 survived
HLHS UAS, MA, AA Norwood 3.1 35 39 17 survived
HLHS UAS, MA, AA Hybrid 3.9 38 40 13 survived
HLHS UAS, MA, AA Norwood 3.7 35 40 16 survived
HLHS UAS, MS, AA Norwood 3.2 32 36 25 survived
HLHS UAS, MA, AA, LAI Norwood 3.6 35 41 6 survived
HLHS UAS, MA, AA Norwood 3.1 37 38 17 survived
HLHS UAS, MA, AA Norwood 3.0 37 38 4 survived
HLHS UAS, MA, AA Hybrid, Norwood 2.8 35 37 119 survived
HLHS UAS, MA, AA Norwood 3.6 35 39 14 survived
Group 4 HLHS I/HRAS (n = 3)
HLHS, MS, AA, TAPVC Fetal stent, Norwood 3.1 32 38 99 survived
HLHS I/HRAS, MS, AA Fetal stent, Hybrid 3.0 35 40 46 deceased (2 weeks)
HLHS I/HRAS, MA, AA Fetal stent NA 36 NA NA deceased (36 weeks GA)
Ranges are given as [min,max].
BW birth weight, GACMR gestational age at CMR, GAbirth gestational age at birth, ICU intensive care unit, AS/CoA aortic stenosis and/or aortic coarctation,
THAA tubular hypoplasia of the aortic arch, MS mitral stenosis, AS aortic stenosis, MS mitral stenosis, VSD ventricular septal defect, HLHS hypoplastic left heart
syndrome, UAS unrestrictive atrial septum, AA aortic atresia, MA mitral atresia, LAI left isomerism, I/HRAS intact or highly restrictive atrial septum, TAPVC totally
anomalous pulmonary venous connection, NA data is not available or not appropriate.
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nificantly lower AAo flow (p < 0.001) compared to nor-
mals (Group 1). The reduction in AAo flow in this
group was associated with reduced FO flow (p = 0.0013)
compared to normal fetuses, as shown in Table 2 and
Figure 1.
All fetuses with AS/CoA (Group 2) were eventually
able to undergo a biventricular repair, although two
underwent Hybrid procedures in the neonatal period
with subsequent conversion to a biventricular repair at
six months of age. One fetus underwent a neonatal Ross
procedure and mitral valve replacement. The remainder
of the fetuses underwent coarctation repairs, usuallywith some patching of the aortic arch. Fetuses with
lower AAo flows tended to require more complex re-
pairs, although there was a considerable overlap of AAo
flows with respect to type of repair.
Pulmonary blood flow, pulmonary venous Doppler, and
lymphangectasia
Figure 2d demonstrates low PBF in the three fetuses
with PVO (Group 4) compared with those with no PVO
(Groups 2 and 3) (p = 0.0016). There was a wide range
of PBF in fetuses with left-sided CHD without PVO
(Groups 2 and 3), similar to normal fetuses (Group 1).
We found no correlation between fetal PBF and
Table 2 PC CMR measurements of blood flow by anatomical and physiological group
CVO MPA AAo SVC PBF FO DA DAo UV
Group 1 Normal (n = 12)
540 327 198 147 106 107 220 273 160
[419,734] [229,440] [145,272] [107,279] [6,178] [5,204] [173,287] [163,418] [101,311]
Group 2 AS/CoA (n = 7)
454 351 89 134 78 25 266 253 153
[392,569] [321,400] [51,152] [107,152] [40,152] [−49,69] [238,318] [199,324] [108,198]
Group 3 HLHS UAS (n = 13)
456 456 0 132 81 −81 358 246 133
[350,596] [350,596] [0,0] [70,231] [30,140] [−140,-30] [300,456] [165,337] [101,165]
Group 4 HLHS I/HRAS (n = 3)
331 331 0 112 21 −21 300 227 135
[114,479] [114,479] [0,0] [21,195] [10,38] [−38,-10] [89,427] [75,307] [57,251]
Flows are given as mean and range in ml/min/kg body weight. Ranges are given as [min,max].
CVO combined ventricular output, MPA main pulmonary artery, AAo ascending aorta, SVC superior vena cava, PBF pulmonary blood flow, FO foramen ovale,
DA ductus arteriosus, DAo descending aorta, UV umbilical vein, AS/CoA aortic stenosis and/or aortic coarctation, HLHS hypoplastic left heart syndrome,
UAS unrestrictive atrial septum, I/HRAS intact or highly restrictive atrial septum.
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fetuses with HLHS with UAS (Group 3).
All three fetuses with HLHS with I/HRAS had low
PBF and PV VTI ratio less than 5 by Doppler. These
were the only three fetuses who had lung MR appear-
ances suggestive of PL. PL was confirmed by biopsy or
autopsy in all three. The fetal lung imaging, postnatal
chest CT, and lung biopsy of one subject with obstructed
pulmonary venous return is shown in Figure 3. All three
of these fetuses underwent fetal atrial septal stenting. In
two of these, blood flows were measured by CMR
shortly prior to the procedure and one week after.
Figure 4 shows a considerable increase in PBF in these
two fetuses following the interventions. Despite the im-
provement in PBF, all of the fetuses undergoing in-utero
stenting had bad outcomes. There was one fetal demise
resulting from thrombosis complicating the stent, which
caused a myocardial infarction. One died soon after the
Hybrid with a combination of pulmonary hypertension
and low cardiac output syndrome. One survived a long
intensive care course but sustained significant brain
injuries.
All fetuses with PL by CMR had a PV VTI ratio of less
than 5. Low PBF was also present in some fetuses with-
out PVO, including normal fetuses. However, high PBF
was associated with the absence of pulmonary venous
obstruction and PL. The relationship between PBF, PV
VTI, and PL is shown in Figure 5.
Cerebral blood flow and brain volumetry
Cerebral blood flow could not be directly measured due
to the small size of the vessels supplying and draining
the brain. However, we used SVC flow as a surrogate for
cerebral blood flow, assuming the flow from the othersources of venous return to the SVC, primarily the mus-
culoskeletal system of the head and upper extremities
was likely to be reasonably constant. In normal fetuses,
there was a narrow range of SVC flows around the mean
of 147 ml/min/kg with the exception of one outlier,
which had high flows throughout the circulation likely
due to a hyperdynamic state of unknown cause. Figure 2c
shows a similar mean SVC flow of 130 ml/min/kg in all
fetuses with left-sided CHD, but with higher variance
(p = 0.018).
MR derived brain weights for the normal and the dis-
ease groups were plotted on a graph of normal ranges
taken from a previously published large autopsy series,
shown in Figure 6 [23]. Six of the fetuses with CHD had
brain weights at or below the 5th centile for gestational
age, while none of the normal control fetuses had brain
weights below the 25th centile. These smaller brains
were found in subjects with CHD despite normal fetal
weights and normal birth weights.
We found no correlation between brain weight and
flow in the SVC, AAo or CVO when the fetuses with left
sided CHD were analysed according to anatomical sub-
type or as a whole. Neither did we find any correlation
between SVC flow or brain weight with middle cerebral
artery or UA Doppler resistive index, or aortic isthmus
size or Doppler gradient.
Discussion
The feasibility of measurement of the distribution of the
fetal circulation using PC CMR in fetuses with left-sided
CHD is established by this study. When CMR was
performed towards the end of the pregnancy, a compre-
hensive dataset could be obtained in all subjects with a



























































Figure 1 Models of distribution of fetal blood flow as percentage of combined ventricular output by anatomical and physiological
group, based on PC CMR measurements. LA-left atrium; RA-right atrium; LV-left ventricle; RV-right ventricle; CVO-combined ventricular output;
MPA-main pulmonary artery; AAo-ascending aorta; SVC-superior vena cava; PBF-pulmonary blood flow; FO-foramen ovale; DA-ductus arteriosus;
DAo-descending aorta; UA-umbilical artery; UV-umbilical vein; CA-coronary artery; CS-coronary sinus; AS/CoA-aortic stenosis and/or aortic
coarctation; PVO-pulmonary vein obstruction; HLHS-hypoplastic left heart syndrome; UAS-unrestrictive atrial septum; I/HRAS-intact or highly
restrictive atrial septum.
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been studied in animals and humans using radioactive
microspheres and ultrasound [17,24-28]. The CMR find-
ings in normal controls are detailed in our previous
paper [8] and are generally consistent with previous esti-
mates. One new observation was the wide range of PBF
and FO flow found in normal fetuses. In the setting of a
rather constant AAo flow, we found an inverse relation-
ship between these two competing sources of venous re-
turn to the left ventricle. There is some evidence to
suggest this variation in FO flow results from variation
in the streaming pattern of the umbilical venous returnat the ductus venosus and FO and the associated
changes in pulmonary vascular resistance that occur in
response to changes in placental function [17,29]. Recent
experimental lamb and human Blood Oxygen
Dependent MR data showing that brain oxygenation is
maintained at a constant level during fetal hypoxia and
hyperoxia indicate that the primary function of this vari-
ation in streaming may be the maintenance of a constant
oxygen content of the blood supplied to the fetal brain
[30,31].
Cardiac output [32], pulmonary vascular resistance






































































Figure 2 Comparison of flows by anatomical and physiological group. Mean (black bars) and individual measurements (coloured bars) for
(a) CVO, (b) AAo, (c) SVC, and (d) PBF. Significance level is indicated (* p < 0.05, ** p < 0.01, *** p < 0.001). HLHS consists of Groups 3 (HLHS UAS)
and 4 (HLHS I/HRAS). All Left-Sided CHD combines Groups 2 through 4. PVO consists of Group 4 (HLHS I/HRAS), while No PVO consists of Groups
2 (AS/CoA) and 3 (HLHS UAS). CVO-combined ventricular output; AAo-ascending aorta; SVC-superior vena cava; PBF-pulmonary blood flow; AS/
CoA-aortic stenosis and/or aortic coarctation; PVO-pulmonary vein obstruction; HLHS-hypoplastic left heart syndrome; UAS-unrestrictive atrial
septum; I/HRAS-intact or highly restrictive atrial septum.
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discussed below. The accurate identification of a restrict-
ive atrial septum in HLHS by PV VTI ratio is an ex-
ample of the clinical utility of fetal hemodynamic
assessment in CHD, as this enables accurate identifica-
tion of fetuses that may require emergency neonatal
intervention [35,36]. We were interested in exploring
whether flow measurements made in fetuses with left-
sided CHD using CMR could contribute useful add-
itional information to the usual echocardiographic
assessment.
Right and left ventricular output
In keeping with previous echocardiographic fetal flow
measurements, our study indicates an average reduction
of approximately 20% in CVO in HLHS compared to
normals [32,36]. This would suggest that while the RV
compensates to some degree for the absent LV output inHLHS, there may be an upper limit on RV performance.
In general, the 20% reduction in CVO in HLHS and
other less severe forms of left sided CHD appears to be
well tolerated, although it may explain the mild growth
restriction seen in newborns with HLHS [37]. The very
low CVO seen in the fetus that suffered a myocardial in-
farction following atrial septal stenting is an example of
how the measurement of flow by CMR may be helpful
for assessing ventricular dysfunction, as the severity of
the cardiac insufficiency had not been appreciated by
echocardiography in this case. With the exception of this
fetus, we noted an increase in MPA flow in all fetuses
with left-sided CHD compared with controls. This in-
crease in RV output is expected because the increased
afterload imposed by left ventricular outflow tract ob-
struction results in reduced FO flow and therefore in-
creased RV preload. The increase in RV output is also
associated with increased DA flow, which balances the
ab
c
Figure 3 Fetal lung CMR suggestive of pulmonary
lymphangectasia confirmed by lung biopsy and postnatal CT in
subject with pulmonary venous obstruction. (a) Axial single shot fast
spin echo with half Fourier image of the fetal chest demonstrating
linear structures extending to the surface of the lung (arrow) suggestive
of pulmonary lymphangectasia. The diagnosis was confirmed by (b)
lung biopsy showing dilated lymphatics (arrow) and (c) postnatal high
resolution CT showing thickening of the interlobular septae (arrow).
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isthmus. It also compensates for the reduction in AAo flow
by providing retrograde flow to the aortic arch. Retrograde
aortic isthmus flow is the principle supply of head and
upper extremity flow in fetuses with HLHS, but also con-
tributes and average of one quarter of head and upper ex-
tremity flow in fetuses with less severe forms of left-sided
CHD such as those with AS and CoA. The demonstration
of retrograde isthmus flow in fetuses that subsequently de-
velop coarcation is in keeping with previous fetal echocar-
diographic studies [38], and suggests that in some patients
with arch hypoplasia the discrete isthmus narrowing may
occur only after birth, possibly in conjunction with postna-
tal ductal constriction.
In fetuses with HLHS the upper body, lower body, and
pulmonary circulation share a common supply of blood
flow from the MPA. Rudolph speculated that this would
result in a higher than normal oxygen content of blood
reaching the pulmonary circulation, and a lower than
normal oxygen content of blood reaching the cerebral
circulation, with the possibility of cerebral and pulmon-
ary vasodilation [17]. However, he also suggested that
anatomic obstruction at the atrial septum and aortic
isthmus might limit pulmonary and cerebral blood flow.
We observed similar mean flows to each of the vascular
beds in HLHS compared with normal controls, although
as Rudolph predicted, we found wide variation in these
flows as follows.
Fetal pulmonary circulation
As streaming of the umbilical venous return across the
ductus venosus towards the FO is likely to be less effect-
ive in the fetal circulation with left-sided obstructive
CHD, and third trimester pulmonary vascular resistance
is inversely proportional to the oxygen content of
pulmonary arterial blood [17], the range of PBF in
fetuses with left-sided CHD may reflect variation in
oxygen delivery from the placenta. Cordocentesis data
from normal late gestation pregnancies suggest that um-
bilical vein saturation ranges from 60 to 80% [39]. We
would therefore suggest that in fetuses with left-sided
CHD with good placental function without PVO we
might expect high PBF. We did indeed find examples of
fetuses with left-sided CHD with PBF approaching
200 ml/min/kg, similar to the most pulmonary
vasodilated normals, and at 81 ml/min/kg (18% of
CVO), the mean PBF in the HLHS with UAS group was
similar to the 106 ml/min/kg (19% of CVO) found in
normals. The low PBF seen in fetuses with PVO is likely
due to the increased lung resistance resulting from pul-
monary venous hypertension. By contrast with the post-
natal circulation, the presence of the DA in the fetal
circulation offers an alternate route for the RV output to













































Figure 4 Increased pulmonary blood flow following fetal atrial septal stenting. (a) Pulmonary blood flow in the two cases that underwent
fetal intervention to decompress the pulmonary veins, where a fetal CMR flow assessment was performed (pre) before and (post) one to two
weeks after the intervention. (b) Flow curves from the left pulmonary artery in one subject that underwent fetal intervention to decompress the
left atrium. The dotted line shows the flow (pre) prior to intervention and the solid line show the flow (post) one week after the intervention.
HLHS-hypoplastic left heart syndrome; I/HRAS-intact or highly restrictive atrial septum.
Al Nafisi et al. Journal of Cardiovascular Magnetic Resonance 2013, 15:65 Page 9 of 12
http://jcmr-online.com/content/15/1/65increase in lung resistance could therefore result in the
dramatic fall in PBF that is seen in these fetuses.
Previous authors have estimated a prevalence of re-
striction at the atrial septum in HLHS of up to 22%, with
an intact atrial septum present in 6% [40]. The elevated
pulmonary venous pressure in fetuses with HLHS with
I/HRAS not only results in low PBF but also in develop-
mental and histological changes within the lung vascula-
ture, characterized by arterialization of pulmonary veins
and thickening and reduced calibre of the small pulmon-
ary arteries [41]. This is frequently associated with dila-
tion of the pulmonary lymphatics, which is thought to























Pulmonary Blood Flow (ml/min/kg)
PVO
no PVO
Figure 5 Relationship between pulmonary vein velocity time
integral ratio by Doppler and pulmonary blood flow by CMR.
Fetuses with pulmonary lymphangectasia (PVO, Group 4) are
compared with fetuses with normal lungs (no PVO, Groups 2 and 3).
VTI-velocity time integral; PVO-pulmonary vein obstruction.increased hydrostatic forces in the vessels [42]. Ante-
natal detection of an I/HRAS is currently routinely
achieved by assessment of the pulmonary venous flow
pattern by Doppler echocardiography [19,35,42]. A low
PV VTI ratio is highly suggestive of atrial septal restric-
tion. It is therefore not surprising to find that fetuses
with CMR findings suggestive of PL had low PV VTI ra-
tios. These fetuses also had uniformly low PBF by CMR
(Figure 5). However, there were examples of fetuses with
similarly low PBF without evidence of PVO, presumably
reflecting upstream pulmonary vasoconstriction. By con-
trast, no fetus with high PBF by CMR had signs of PL or
an abnormal VTI, so normal or high PBF by CMR
would appear to be predictive of an absence of PVO.
Restriction at the atrial septum is one of the most im-
portant risk factors for adverse outcome in fetuses with
HLHS before and after surgery for both staged recon-
struction and heart transplantation [43,44]. Affected ne-
onates present with profound hypoxemia and may die or
sustain a significant insult before medical or surgical
intervention. A number of centres now perform intra-
uterine fetal left atrial decompression with the aim of
preventing further pulmonary vascular damage and re-
versing some of the pathological changes already present
[45]. The increase in PBF to near normal levels seen in
the three fetuses undergoing fetal atrial stenting, shown
in Figure 4, supports this approach. While the initial
postnatal clinical presentation of these patients was
more stable than those born at our centre with I/HRAS
in the era prior to fetal intervention, their long-term
outcome remains poor [46]. We would suggest that the
antenatal diagnosis of PL by CMR complements the
Doppler assessment of the fetal pulmonary circulation in
HLHS with I/HRAS. CMR provided additional evidence
of the presence of significant pulmonary vascular disease



















Figure 6 Relationship between brain weight and gestational
age. Normal (Group 1), AS/CoA (Group 2), and HLHS (Groups 3 & 4)
anatomical and physiological groups plotted against normal median
(solid line) and 5th and 95th percentiles (dashed lines), based on a
previously published autopsy series [24]. AS/CoA-aortic stenosis and/
or aortic stenosis; HLHS-hypoplastic left heart syndrome.
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intervention.
Fetal cerebral circulation
Children with HLHS have reduced IQ and a variety of
deficits of neurocognitive function [47]. While some of
this is likely to be due to neurologic insults occurring
during cardiac surgery and the post-operative period, re-
cent studies have suggested that newborns with HLHS
have brain abnormalities at birth [10] and that their
brain growth and metabolism are abnormal towards the
end of gestation [48]. One possible etiology is inadequate
cerebral perfusion due to abnormal fetal hemodynamics.
In the normal fetus, the brain is perfused by antegrade
flow from the left ventricle via the AAo and aortic arch.
The AAo is a relatively large vessel, carrying a mean of
37% of the CVO in the normal fetus [8]. In fetuses with
any degree of left-sided CHD, antegrade flow in the AAo
is limited, and the DA supplies a significant proportion
of the cerebral blood flow via retrograde flow in the aor-
tic arch. The reduced pulsatility found in the middle
cerebral artery in fetuses with HLHS is one piece of evi-
dence to suggest that cerebral vascular hemodynamics
are affected by this anatomy [34,49].
We were interested in the relationship between fetal
brain growth and cerebral perfusion. We found that fe-
tuses with left-sided CHD had a mean SVC flow similar to
normals (Figure 2c). However, by contrast with the normal
controls that had a narrow range of SVC flows, we found
wide variations in SVC flow from 21–231 ml/min/kg.Possible causes for low SVC flow include obstruction to
retrograde flow at the aortic isthmus and stealing to other
parts of the circulation in the setting of limited CVO. Fetal
cerebral blood flow is also affected by the oxygen content
of the blood in the aortic arch, with a powerful hypoxic
cerebral vasodilation mechanism in operation [50]. Fur-
thermore, the normal fetus appears to regulate the oxygen
content of ascending aortic blood despite variation in
oxygen delivery from the placenta though variation in the
ductus venosus and foramen ovale shunt [8,29-31]. How-
ever, the fetus with left-sided cardiac obstruction is not
likely to be able to vary foramen ovale flow to regulate the
oxygen content of ascending aortic in the same way as the
normal fetus due to the obligate left to right or reduced
right to left shunt at atrial level. Therefore the oxygen con-
tent of ascending aortic blood and therefore the cerebral
blood supply are likely to be more strongly coupled to
oxygen delivery by the placenta. The wide variation in
SVC flow we found in fetuses with left-sided CHD may
reflect the need for more cerebral vasoreactivity to
adequately oxygenate the brain in the setting of normal
variations in placental oxygen delivery. The absence of any
correlation between UA Doppler and SVC flow could
be interpreted as contradictory to this hypothesis.
However, UA Doppler has been shown to be an in-
sensitive measure of late onset placental insufficiency
[51]. The very low SVC flow of 21 ml/min/kg seen in
the fetus with a myocardial infarction is in keeping
with the observation that brain-sparing physiology fails
with severe fetal distress, which may be a sign of
imminent fetal demise [52].
We were surprised to find no relationship between
middle cerebral artery Doppler and SVC flow. However,
Rudolph has suggested that the middle cerebral artery
Doppler is not an accurate reflection of cerebral vascular
resistance in HLHS because of the possibility of up-
stream obstruction [17]. Another explanation for the
lack of correlation we found between middle cerebral ar-
tery Doppler, SVC flow, and brain volume may be that
our CMR study represented a “snapshot” of the fetal cir-
culation during late gestation. Our finding of lower brain
weights in subjects with CHD is in keeping with a previ-
ous study, which detected brain weights more than 2
standard deviations below the normal mean in 27% of
fetuses with HLHS [53]. While the significance of abnor-
malities of fetal cerebral perfusion are not known with
respect to long-term neuro-developmental outcome, we
believe that an approach combining fetal brain imaging
and PC CMR may contribute to the growing body of
information being gathered regarding this issue.
Study limitations
The small sample size of this study mandates a cautious
approach to evaluating the findings. Our protocol
Al Nafisi et al. Journal of Cardiovascular Magnetic Resonance 2013, 15:65 Page 11 of 12
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would have been interesting to know how the distribu-
tion of flow varied over time. The current technique is
not suitable for making flow measurements at younger
gestational ages, although this would be desirable. For a
fuller understanding of fetal hemodynamics, measure-
ment of the oxygen content of fetal blood would be a
very helpful addition to flow quantification. With the de-
velopment of fetal MR oximetry and blood oxygen level
dependent imaging, a better understanding of oxygen
handling by the fetal circulation may be available in the
future [30,31,54]. We also lacked any long term neuro-
developmental follow up in this group and believe fur-
ther studies to examine the mechanisms and importance
of fetal brain developmental delay in CHD should be a
priority.
Conclusions
PC CMR facilitates an understanding of the distribution
of the fetal circulation in left-sided CHD and offers those
providing care an additional tool for monitoring pro-
gress during fetal life at no additional risk to the mother
or fetus [55]. The findings are generally in keeping with
previous estimates of flow in the fetal circulation in
CHD, but offer a more comprehensive assessment of
blood flow distribution in this setting. By combining PC
CMR with fetal organ volumetry and T2-weighted im-
aging, CMR allows investigation of the impact of fetal
hemodynamics on fetal brain and lung development,
and has the potential to contribute to the planning of
fetal therapy and postnatal interventions. The identifica-
tion of pulmonary lymphangectasia due to pulmonary
venous hypertension in fetuses with HLHS with I/HRAS
may be helpful to confirm the presence of fetal pulmon-
ary vascular disease in this most malignant subgroup of
fetuses with left-sided CHD. With this initial cohort, we
have shown that CMR is feasible for studying late gesta-
tion fetuses with left-sided CHD and propose that, with
larger numbers and long term follow up, we might be
able to offer additional information regarding postnatal
outcome.
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